CVRx, Inc.
General ticker "CVRX" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $237.1M (TTM average)
CVRx, Inc. follows the US Stock Market performance with the rate: 11.5%.
Estimated limits based on current volatility of 11.9%: low 5.13$, high 6.51$
Factors to consider:
- Total employees count: 206 (+3.0%) as of 2024
- US accounted for 92.0% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Regulatory and compliance, Product liability, Strategic risks and growth management, Labor/talent shortage/retention, Acquisition/divestiture risks
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [6.01$, 15.12$]
- 2025-12-31 to 2026-12-31 estimated range: [5.25$, 13.49$]
Financial Metrics affecting the CVRX estimates:
- Negative: with PPE of -4.7 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -13.75 <= 0.04
- Positive: 42.53 < Shareholder equity ratio, % of 53.26 <= 64.17
- Negative: negative Industry operating cash flow (median)
- Positive: Interest expense per share per price, % of 1.54 <= 3.31
- Positive: Inventory ratio change, % of -2.75 <= -0.76
Short-term CVRX quotes
Long-term CVRX plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $22.47MM | $39.30MM | $51.29MM |
| Operating Expenses | $65.00MM | $82.40MM | $110.78MM |
| Operating Income | $-42.53MM | $-43.10MM | $-59.49MM |
| Non-Operating Income | $1.21MM | $2.05MM | $-0.42MM |
| Interest Expense | $0.17MM | $1.80MM | $4.40MM |
| R&D Expense | $9.95MM | $11.63MM | $11.13MM |
| Income(Loss) | $-41.32MM | $-41.05MM | $-59.91MM |
| Taxes | $0.11MM | $0.15MM | $0.06MM |
| Profit(Loss)* | $-41.43MM | $-41.20MM | $-59.97MM |
| Stockholders Equity | $109.18MM | $75.95MM | $71.06MM |
| Inventory | $6.96MM | $10.98MM | $12.11MM |
| Assets | $124.94MM | $115.23MM | $133.41MM |
| Operating Cash Flow | $-42.68MM | $-39.02MM | $-39.14MM |
| Capital expenditure | $0.69MM | $0.59MM | $1.36MM |
| Investing Cash Flow | $-0.69MM | $-0.59MM | $-1.36MM |
| Financing Cash Flow | $7.49MM | $23.98MM | $55.87MM |
| Earnings Per Share** | $-2.02 | $-1.99 | $-2.65 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.